Journal ArticleOPEN ACCESS

The Case for Combined-Modality Therapy for Limited-Stage Hodgkin's Disease

  • Hill-Kayser C
  • Plastaras J
  • Tochner Z
  • et al.
The Oncologist (2012) 17(8) 1006-1010
DOI: 10.1634/theoncologist.2012-0148
2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Results of the Hodgkin's Disease.6 trial are critically examined in light of the advances in radiation therapy techniques that have occurred since it was initiated. The ultimate findings of the HD.6 trial do not close the case for combined-modality treatment of limited-stage Hodgkin's disease.

Cite

CITATION STYLE

APA

Hill-Kayser, C. E., Plastaras, J. P., Tochner, Z., & Glatstein, E. (2012). The Case for Combined-Modality Therapy for Limited-Stage Hodgkin’s Disease. The Oncologist, 17(8), 1006–1010. https://doi.org/10.1634/theoncologist.2012-0148

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free